THE AZELAPRAG CLINICAL TRIALS DIARIES

AMG 986 exposures greater nonlinearly with escalating doses; minimal accumulation was observed. In HF with diminished ejection portion patients, there were numerical raises in per cent changes from baseline in LV ejection fraction and stroke volume by volumetric assessment with AMG 986 vs placebo (stroke quantity improve not recapitulated by Dopple